Todd Franklin Watanabe Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

Todd Franklin Watanabe is Director of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 838,430 shares of ARQT, which is worth approximately $12.6 Million. The most recent transaction as insider was on Sep 07, 2021, when has been sold 1,000 shares (Common Stock) at a price of $1.68 per share, resulting in proceeds of $1,680. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 838K

0.93% 3M change

67.01% 12M change

Total Value Held $12.6 Million

Todd Franklin Watanabe Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 07 2021	BUY Exercise of conversion of derivative security	$1,680 $1.68 p/Share	1,000 Added 0.17%	595,779 Common Stock
Aug 05 2021	SELL Open market or private sale	$20,810 $20.81 p/Share	1,000 Reduced 0.17%	594,779 Common Stock
Aug 05 2021	BUY Exercise of conversion of derivative security	$1,680 $1.68 p/Share	1,000 Added 0.17%	595,779 Common Stock
Jul 06 2021	SELL Open market or private sale	$46,515 $26.58 p/Share	1,750 Reduced 0.29%	594,779 Common Stock
Jul 06 2021	BUY Exercise of conversion of derivative security	$2,940 $1.68 p/Share	1,750 Added 0.29%	596,529 Common Stock
Jun 07 2021	SELL Open market or private sale	$46,113 $26.35 p/Share	1,750 Reduced 0.29%	594,779 Common Stock
Jun 07 2021	BUY Exercise of conversion of derivative security	$2,940 $1.68 p/Share	1,750 Added 0.29%	596,529 Common Stock
May 07 2021	SELL Open market or private sale	$26,250 $35.0 p/Share	750 Reduced 0.13%	593,773 Common Stock
May 07 2021	BUY Exercise of conversion of derivative security	$1,260 $1.68 p/Share	750 Added 0.13%	594,523 Common Stock
May 05 2021	SELL Open market or private sale	$59,500 $34.0 p/Share	1,750 Reduced 0.29%	593,773 Common Stock
May 05 2021	BUY Exercise of conversion of derivative security	$2,700 $1.68 p/Share	1,607 Added 0.27%	595,523 Common Stock
Apr 30 2021	SELL Open market or private sale	$52,500 $35.0 p/Share	1,500 Reduced 0.25%	593,916 Common Stock
Apr 05 2021	SELL Open market or private sale	$52,378 $29.93 p/Share	1,750 Reduced 0.29%	595,416 Common Stock
Mar 05 2021	SELL Open market or private sale	$53,462 $30.55 p/Share	1,750 Reduced 0.29%	597,166 Common Stock
Mar 03 2021	BUY Grant, award, or other acquisition	-	32,700 Added 5.18%	598,916 Common Stock
Mar 02 2021	SELL Open market or private sale	$74,145 $35.19 p/Share	2,107 Reduced 0.37%	566,216 Common Stock
Feb 05 2021	SELL Open market or private sale	$341,300 $34.13 p/Share	10,000 Reduced 1.73%	568,323 Common Stock
Feb 05 2021	BUY Exercise of conversion of derivative security	$16,800 $1.68 p/Share	10,000 Added 1.7%	578,323 Common Stock
Sep 29 2020	SELL Open market or private sale	$90,000 $30.0 p/Share	3,000 Reduced 0.53%	566,928 Common Stock
Sep 29 2020	SELL Open market or private sale	$90,000 $30.0 p/Share	3,000 Reduced 0.53%	566,928 Common Stock
Sep 29 2020	BUY Exercise of conversion of derivative security	$5,040 $1.68 p/Share	3,000 Added 0.52%	569,928 Common Stock
Sep 29 2020	BUY Exercise of conversion of derivative security	$5,040 $1.68 p/Share	3,000 Added 0.52%	569,928 Common Stock

TFW

Todd Franklin Watanabe

Director

Westlake Village, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if

Value

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Arcutis Biotherapeutics, Inc.

Track Activities on ARQT

Account